Sign In
Buy MRTX
$58.70
+0 (+0%)
At Close: Apr 19, 2024
Better Buy: Amgen vs. Mirati Therapeutics
07:53am, Tuesday, 27'th Oct 2020
Which one of these biotech stocks has a better chance to provide market-beating gains?
Why Mirati Therapeutics Stock Is Taking Off Today
11:32am, Monday, 26'th Oct 2020
The biotech's positive clinical results announced on Sunday prompted analysts to boost their price targets on the stock.
Tiny Mirati Therapeutics Gets Jump On Giant Amgen In Cancer Drug
11:16am, Monday, 26'th Oct 2020
Tiny Mirati Therapeutics posted positive preliminary data on a colorectal and lung cancer drug therapy in competition with drug giant Amgen, sending MRTX stock soaring to an all-time high. The post Ti
Mirati Will Continue To Shine As It Keeps Delivering Promising Results (NASDAQ:MRTX)
07:48am, Monday, 12'th Oct 2020
Mirati achieves positive results in phase 2 open-label study using sitravatinib to treat patients with metastatic or advanced urothelial carcinoma who have the KRAS mutation.
A phase 1 clinical trial of AMG 510 in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity.
High Hopes for Amgen and Gilead at Europe’s Biggest Cancer Research Conference
08:16pm, Friday, 18'th Sep 2020
Europe’s biggest conference for cancer researchers will be a virtual affair this weekend, but it is still expected to be a big deal for companies like Amgen and for Immunomedics, which just agreed t
Boehringer Ingelheim and Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced a clinical collaboration to evaluate the combination of BI 1701963,
Verastem Oncology Announces Presentation of Updated Phase 1/2 FRAME Study Data at the 2nd Annual RAS-Targeted Drug Development Summit
12:00am, Wednesday, 16'th Sep 2020
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
10X Genomics Inc (NASDAQ: TXG)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Avenue Therapeutics Inc (NASDAQ: ATXI)...
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
Catalent Inc (NYSE: CTLT)
CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
Qorvo Announces Extension of Exchange Offer for 4.375% Senior Notes Due 2029
12:00pm, Friday, 14'th Aug 2020
GREENSBORO, N.C., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that it has extended its registered ex
Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced it has signed an agreement with Mirati Therapeutics, Inc. (NASDAQ:MRTX) to bro
J.P. Morgan: 2 5G Stocks to Consider (And 1 to Avoid)
01:57pm, Wednesday, 12'th Aug 2020
The late, great, Neil Peart wrote, in Tom Sawyer, “He knows changes aren’t permanent, but change is.” His words are an apt description of our modern world, an ever-changing landscape of pending
Affimed N.V. (AFMD) CEO Adi Hoess on Q2 2020 Results - Earnings Call Transcript
03:41pm, Tuesday, 11'th Aug 2020
Affimed N.V. (NASDAQ:AFMD) Q2 2020 Earnings Conference Call August 11, 2020 8:30 a.m.
